The changing epidemiology of sudden death in heart failure Sidney Goldstein OriginalPaper Pages: 93 - 97
Comprehensive adrenergic receptor blockade with carvedilol is superior to beta-1-selective blockade with metoprolol in patients with heart failure: COMET John G. F. Cleland OriginalPaper Pages: 82 - 88
Beta-blockers in heart failure: Is more better? Lawrence BaruchPrabhakara Kunamneni OriginalPaper Pages: 77 - 81
Initiation and use of beta-blockers in class IV heart failure Feras M. BaderJohn F. MacGregorEdward M. Gilbert OriginalPaper Pages: 72 - 76
Inhibition of RAAS—When is it too much? Pablo NavarroRobert MoskowitzThierry H. Le Jemtel OriginalPaper Pages: 57 - 64
Efficacy of aldosterone receptor antagonism in heart failure: Potential mechanisms Karl T. Weber OriginalPaper Pages: 51 - 56
Interactions between the sympathetic nervous system and the RAAS in heart failure Steven R. Goldsmith OriginalPaper Pages: 45 - 50
Ventricular assist devices: Destination therapy or just another stop on the road? Mandeep R. Mehra OriginalPaper Pages: 36 - 40
Cardiac resynchronization therapy—How big of a miracle? Philip B. Adamson OriginalPaper Pages: 30 - 35
Surgical ventricular restoration and other surgical approaches to heart failure Patrick I. McConnellRobert E. Michler OriginalPaper Pages: 21 - 29
Mechanical approaches to alter remodeling Sunil MatiwalaKenneth B. Margulies OriginalPaper Pages: 14 - 18
Structural basis of ventricular remodeling: Role of the myocyte Faqian LiXuejun WangA. Martin Gerdes OriginalPaper Pages: 5 - 8